Inflammation signaling lipidomics studies bioactive lipid mediators that regulate immune responses, inflammatory pathways, tissue repair, disease progression, and resolution biology.
Inflammation signaling is a major area of lipidomics because many lipid molecules act as powerful biological messengers. Lipid mediators such as prostaglandins, leukotrienes, thromboxanes, oxylipins, and specialized pro-resolving mediators influence immune activation, vascular response, oxidative stress, pain, tissue injury, and inflammatory resolution.
At PanorOmics, inflammation signaling is presented as a core lipidomics research area: a bridge between lipid mediator biology, immune regulation, disease mechanisms, biomarker discovery, therapeutic response, and multi-omics inflammation research.
Studying bioactive lipid molecules that regulate inflammation, immune signaling, vascular responses, and tissue repair.
Analyzing how lipid-derived signals influence cytokine activity, immune cell behavior, oxidative stress, and disease-associated inflammation.
Investigating prostaglandins, leukotrienes, thromboxanes, resolvins, and related lipid mediators involved in inflammatory control.
Identifying lipid signaling patterns associated with cancer, cardiovascular disease, metabolic disease, infection, and immune disorders.
High-sensitivity mass spectrometry used to detect and quantify inflammatory lipid mediators across biological samples.
Focused quantification of eicosanoids, oxylipins, prostaglandins, leukotrienes, and specialized pro-resolving mediators.
Broad lipid profiling used to discover inflammation-associated lipid signatures and pathway alterations.
Experimental systems used to study lipid-mediated inflammatory responses in immune, epithelial, endothelial, and disease models.
Computational approaches that support lipid mediator interpretation, inflammatory signature discovery, and pathway modeling.
Measures lipid mediators derived from arachidonic acid that regulate inflammation, pain, vascular tone, and immune response.
Profiles oxidized fatty acid metabolites involved in inflammatory signaling, oxidative stress, and tissue responses.
Studies lipid mediators involved in resolving inflammation and restoring tissue homeostasis.
Analyzes how lipid mediators influence immune cell activation, migration, cytokine signaling, and inflammatory balance.
Identifies lipid signatures associated with inflammatory disease states, disease severity, or therapeutic response.
Combines lipidomics with transcriptomics, proteomics, metabolomics, and clinical data to interpret inflammatory pathways.
Related lipidomic approaches such as lipid profiling, membrane biology, and metabolic regulation are explored across the Lipidomics Research Center.
Early discoveries of prostaglandins established lipid molecules as biologically active regulators of inflammation and physiology.
Research on prostaglandins, leukotrienes, and thromboxanes revealed lipid mediators as central regulators of inflammatory and immune responses.
Inflammation research expanded from individual lipid mediators toward interconnected lipid signaling pathways and regulatory networks.
LC-MS/MS enabled sensitive detection of inflammatory lipid mediators across tissues, fluids, disease models, and clinical samples.
Specialized pro-resolving mediators became important for understanding how inflammation is actively resolved rather than passively stopped.
Integrated omics approaches connect lipid signaling with immune pathways, gene expression, proteins, metabolites, and disease phenotypes.
AI increasingly supports lipid mediator interpretation, inflammatory signature discovery, pathway modeling, and precision medicine research.
Continue exploring the Lipidomics Research Center.
Continue exploring the Lipidomics Research Center.
Continue exploring the Lipidomics Research Center.